Investigating causes of heterogeneity in systematic reviews

Research output: Contribution to journalArticleResearchpeer-review

119 Citations (Scopus)

Abstract

What causes heterogeneity in systematic reviews of controlled trials? First, it may be an artefact of the summary measures used, of study design features such as duration of follow-up or the reliability of outcome measures. Second, it may be due to real variation in the treatment effect and hence provides the opportunity to identify factors that may modify the impact of treatment. These factors may include features of the population such as: severity of illness, age and gender; intervention factors such as dose, timing or duration of treatment; and comparator factors such as the control group treatment or the co-interventions in both groups. The ideal way to study causes of true variation is within rather than between studies. In most situations however, we will have to make do with a study level investigation and hence need to be careful about adjusting for potential confounding by artefactual factors such as study design features. Such investigation of artefactual and true causes of heterogeneity form essential steps in moving from a combined effect estimate to application to particular populations and individuals. Copyright (C) 2002 John Wiley Sons, Ltd.

Original languageEnglish
Pages (from-to)1503-1511
Number of pages9
JournalStatistics in Medicine
Volume21
Issue number11
DOIs
Publication statusPublished - 15 Jun 2002
Externally publishedYes
EventInternational Symposium on Methodological Issues in Systematic Reviews and Meta-Analysis - OXFORD, United Kingdom
Duration: 3 Jul 20005 Jul 2000

Cite this

@article{c789e0b2c7664364b3b026803c9ea486,
title = "Investigating causes of heterogeneity in systematic reviews",
abstract = "What causes heterogeneity in systematic reviews of controlled trials? First, it may be an artefact of the summary measures used, of study design features such as duration of follow-up or the reliability of outcome measures. Second, it may be due to real variation in the treatment effect and hence provides the opportunity to identify factors that may modify the impact of treatment. These factors may include features of the population such as: severity of illness, age and gender; intervention factors such as dose, timing or duration of treatment; and comparator factors such as the control group treatment or the co-interventions in both groups. The ideal way to study causes of true variation is within rather than between studies. In most situations however, we will have to make do with a study level investigation and hence need to be careful about adjusting for potential confounding by artefactual factors such as study design features. Such investigation of artefactual and true causes of heterogeneity form essential steps in moving from a combined effect estimate to application to particular populations and individuals. Copyright (C) 2002 John Wiley Sons, Ltd.",
author = "PP Glasziou and SL Sanders",
year = "2002",
month = "6",
day = "15",
doi = "10.1002/sim.1183",
language = "English",
volume = "21",
pages = "1503--1511",
journal = "Statistics in Medicine",
issn = "0277-6715",
publisher = "John Wiley & Sons",
number = "11",

}

Investigating causes of heterogeneity in systematic reviews. / Glasziou, PP; Sanders, SL.

In: Statistics in Medicine, Vol. 21, No. 11, 15.06.2002, p. 1503-1511.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Investigating causes of heterogeneity in systematic reviews

AU - Glasziou, PP

AU - Sanders, SL

PY - 2002/6/15

Y1 - 2002/6/15

N2 - What causes heterogeneity in systematic reviews of controlled trials? First, it may be an artefact of the summary measures used, of study design features such as duration of follow-up or the reliability of outcome measures. Second, it may be due to real variation in the treatment effect and hence provides the opportunity to identify factors that may modify the impact of treatment. These factors may include features of the population such as: severity of illness, age and gender; intervention factors such as dose, timing or duration of treatment; and comparator factors such as the control group treatment or the co-interventions in both groups. The ideal way to study causes of true variation is within rather than between studies. In most situations however, we will have to make do with a study level investigation and hence need to be careful about adjusting for potential confounding by artefactual factors such as study design features. Such investigation of artefactual and true causes of heterogeneity form essential steps in moving from a combined effect estimate to application to particular populations and individuals. Copyright (C) 2002 John Wiley Sons, Ltd.

AB - What causes heterogeneity in systematic reviews of controlled trials? First, it may be an artefact of the summary measures used, of study design features such as duration of follow-up or the reliability of outcome measures. Second, it may be due to real variation in the treatment effect and hence provides the opportunity to identify factors that may modify the impact of treatment. These factors may include features of the population such as: severity of illness, age and gender; intervention factors such as dose, timing or duration of treatment; and comparator factors such as the control group treatment or the co-interventions in both groups. The ideal way to study causes of true variation is within rather than between studies. In most situations however, we will have to make do with a study level investigation and hence need to be careful about adjusting for potential confounding by artefactual factors such as study design features. Such investigation of artefactual and true causes of heterogeneity form essential steps in moving from a combined effect estimate to application to particular populations and individuals. Copyright (C) 2002 John Wiley Sons, Ltd.

U2 - 10.1002/sim.1183

DO - 10.1002/sim.1183

M3 - Article

VL - 21

SP - 1503

EP - 1511

JO - Statistics in Medicine

JF - Statistics in Medicine

SN - 0277-6715

IS - 11

ER -